Physicochemical Stimulus-Responsive Systems Targeted with Antibody Derivatives
Research output: Contribution to journal › Review › Research › peer-review
The application of monoclonal antibodies and antibody fragments with the advent of recombinant antibody technology has made notable progress in clinical trials to provide a regulated drug release and extra targeting to the special conditions in the function site. Modification of antibodies has facilitated using mAbs and antibody fragments in numerous models of therapeutic and detection utilizations, such as stimuli-responsive systems. Antibodies and antibody derivatives conjugated with diverse stimuli-responsive materials have been constructed for drug delivery in response to a wide range of endogenous (electric, magnetic, light, radiation, ultrasound) and exogenous (temperature, pH, redox potential, enzymes) stimuli. In this report, we highlighted the recent progress on antibody-conjugated stimuli-responsive and dual/multi-responsive systems that affect modern medicine by improving a multitude of diagnostic and treatment strategies.
Original language | English |
---|---|
Journal | Current Molecular Medicine |
Volume | 24 |
Issue number | 10 |
Pages (from-to) | 1250-1268 |
Number of pages | 19 |
ISSN | 1566-5240 |
DOIs | |
Publication status | Published - 2024 |
Bibliographical note
Funding Information:
The project was funded and supported by Shahid Beheshti University of Medical Sciences (Grant number: 32103). The authors would like to thank the Cellular & Molecular Biology Research Center for its kind support.
Funding Information:
The project was funded and supported by Shahid Beheshti University of Medical Sciences (Grant number: 32103).
Publisher Copyright:
© 2024 Bentham Science Publishers.
- Antibody, derivatives of antibody, endogenous stimuli, exogenous stimuli, stimulus-responsive systems, targeted delivery of antibody
Research areas
ID: 403620863